ARTICLE | Company News
Definiens, AstraZeneca deal
November 10, 2014 8:00 AM UTC
AstraZeneca's MedImmune LLC unit will acquire Definiens for $150 million plus undisclosed milestone payments. MedImmune spokesperson Tracy Rossin said the company will use Definiens' Cognition Networ...